Drug profile · INN
patiromer
VELTASSA
patiromer (VELTASSA) is a potassium chelating agent. Associated with Seqirus (Australia) Pty Ltd.
EMA: approved TGA: approved Various (V03) V03AE09
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — patiromer
- Class
- Various (V03)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
patiromer (VELTASSA) is a potassium chelating agent. Associated with Seqirus (Australia) Pty Ltd.
Key facts
INN patiromer
Brand VELTASSA
Mechanism Potassium chelating agent
Target Potassium
Therapeutic class Various (V03)
ATC code V03AE09
Originator Seqirus (Australia) Pty Ltd
Mechanism of action
Potassium chelating agent
Primary target: Potassium
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is patiromer?
patiromer (VELTASSA) is a potassium chelating agent. Associated with Seqirus (Australia) Pty Ltd.
What is the brand name for patiromer?
VELTASSA is a marketed brand name for patiromer. Check FDA Drugs@FDA for the current US label holder and prescribing information.